Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction

IMPORTANCE: There is growing recognition that patients may respond differently to therapy and that the average treatment effect from a clinical trial may not apply equally to all candidates for a therapy. OBJECTIVE: To determine whether, among patients with an ischemic stroke or transient ischemic a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Neurol
Main Authors: Kernan, Walter N., Viscoli, Catherine M., Dearborn, Jennifer L., Kent, David M., Conwit, Robin, Fayad, Pierre, Furie, Karen L., Gorman, Mark, Guarino, Peter D., Inzucchi, Silvio E., Stuart, Amber, Young, Lawrence H.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2017
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5710663/
https://ncbi.nlm.nih.gov/pubmed/28975241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2017.2136
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados